Fight Looms Over Control Of U.S. Data

WASHINGTON—A quiet battle is being waged here to win control over certain types of unclassified information, including scientific data, despite the Reagan administration’s decision earlier this year not to broaden such control. The decision last March not to create a new category of “sensitive hut unclassified” information has not stopped the Pentagon’s National Security Agency from continuing to set policies for defining and protecting classified information. No

Written byTed Agres
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WASHINGTON—A quiet battle is being waged here to win control over certain types of unclassified information, including scientific data, despite the Reagan administration’s decision earlier this year not to broaden such control.

The decision last March not to create a new category of “sensitive hut unclassified” information has not stopped the Pentagon’s National Security Agency from continuing to set policies for defining and protecting classified information. Nor has the administration revised the policy directive that gives NSA the lead role in such an effort. At the same time, a new report from the Congressional Office of Technology Assessment questions whether “a defense agency should control matters that are central to civilian interests.”

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies